Clarient, a provider of anatomic pathology and molecular testing services, has announced that its senior vice president and CFO, Jim Agnello, will step down from that position.
Subscribe to our email newsletter
Mr Agnello is expected to continue to serve as CFO until his successor is appointed and to remain with the company as an employee or consultant for a transitional period thereafter.
Ron Andrews, CEO of Clarient, said: “Jim came into a challenging environment two years ago and has established a financial infrastructure upon which we can now build. I would like to thank Jim for his efforts to move us closer to profitability as demonstrated by our recent achievements in the first quarter of 2008.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.